MCLE — Medicale Cashflow Statement
0.000.00%
Last trade - 00:00- $0.18m
- $0.29m
Annual cashflow statement for Medicale, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.032 | -0.046 | -0.038 | -0.058 | -0.041 |
| Amortisation | |||||
| Non-Cash Items | — | 0.007 | 0 | 0 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Changes in Working Capital | 0.012 | 0.012 | 0.011 | -0.025 | 0.018 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.018 | -0.025 | -0.026 | -0.084 | -0.023 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | — | — |
| Financing Cash Flow Items | 0.011 | 0.006 | 0.026 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.036 | 0.006 | 0.026 | 0.084 | 0.023 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.018 | -0.018 | 0 | 0 | -0 |